{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:34:44Z","timestamp":1794044084125,"version":"4.8.0"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Cystic fibrosis (CF) is an autosomal recessive disease due to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. With the advent of highly effective modulator therapy targeting the abnormal CFTR protein, people with CF (PwCF) are living more than 40 years longer than the pre-modulator therapy era. As a result, PwCF are facing new challenges of managing similar comorbidities affecting the average aging population. While CF is notoriously identified as a chronic respiratory disease, the multisystem presence of the CFTR gene can contribute to other organ-related complications acutely, but also heighten the likelihood of chronic conditions not routinely encountered in this cohort. In this overview, we will focus on risk factors and epidemiology for PwCF as they relate to cardiovascular disease, dyslipidemia, CF-related diabetes, pulmonary hypertension, obstructive sleep apnea, CF-liver disease, bone health and malignancy. With increased awareness of diseases affecting a newly aging CF population, a focus on primary and secondary prevention will be imperative to implementing a comprehensive care plan to improve long-term morbidity and mortality.<\/jats:p>","DOI":"10.3390\/life13061305","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:40:56Z","timestamp":1685583656000},"page":"1305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Future Comorbidities in an Aging Cystic Fibrosis Population"],"prefix":"10.3390","volume":"13","author":[{"given":"Javier Humberto","family":"Ticona","sequence":"first","affiliation":[{"name":"Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY 11549, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lapinel","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New Hyde Park, NY 11042, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, New Hyde Park, NY 11042, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and F\u00e9rec, C. (2020). The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2018.00020","article-title":"Cystic Fibrosis-Related Diabetes","volume":"9","author":"Kayani","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ame2.12180","article-title":"A review of cystic fibrosis: Basic and clinical aspects","volume":"4","author":"Chen","year":"2021","journal-title":"Anim. Model Exp. Med."},{"key":"ref_4","unstructured":"Cystic Fibrosis Foundation (2021). Patient Registry 2021 Annual Data Report, Cystic Fibrosis Foundation."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"ref_6","unstructured":"Global Burden of Disease Study 2013 Collaborators (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 743\u2013800."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lopez, A., Daly, C., Vega-Hernandez, G., MacGregor, G., and Rubin, J.L. Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. J. Cyst. Fibros., 2023.","DOI":"10.1016\/j.jcf.2023.02.004"},{"key":"ref_8","first-page":"e16723","article-title":"Cardiovascular System Involvement in Cystic Fibrosis","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Onady, G.M., and Farinet, C.L. (2006). An adult cystic fibrosis patient presenting with persistent dyspnea: Case Report. BMC Pulm. Med., 6.","DOI":"10.1186\/1471-2466-6-9"},{"key":"ref_10","first-page":"100308","article-title":"Coronary artery disease in patients with cystic fibrosis\u2014A case series and review of the literature","volume":"30","author":"Sandouk","year":"2022","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1258\/jrsm.2010.s11010","article-title":"Ischaemic heart disease\u2014A new issue in cystic fibrosis?","volume":"103","author":"Perrin","year":"2010","journal-title":"J. R. Soc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1378\/chest.12-1934","article-title":"Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis","volume":"143","author":"Poore","year":"2013","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00044009","article-title":"Increased augmentation index in patients with cystic fibrosis","volume":"34","author":"Hull","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.lpm.2017.05.011","article-title":"Current and emerging comorbidities in cystic fibrosis","volume":"46","author":"Ronan","year":"2017","journal-title":"Presse M\u00e9d."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1159\/000341479","article-title":"Protective role of cardiac CFTR activation upon early reperfusion against myocardial infarction","volume":"30","author":"Uramoto","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2009.09.002","article-title":"Prevalence of dyslipidemia in adults with cystic fibrosis","volume":"9","author":"Rhodes","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1590\/S1806-37132008001000012","article-title":"Cystic fibrosis-related dyslipidemia","volume":"34","author":"Lima","year":"2008","journal-title":"J. Bras. Pneumol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ajcn\/75.6.1005","article-title":"Abnormal lipid concentrations in cystic fibrosis","volume":"75","author":"Figueroa","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MCO.0b013e32832595b7","article-title":"Lipid metabolism in cystic fibrosis","volume":"12","author":"Worgall","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2019.04.001","article-title":"Cystic fibrosis dyslipidaemia: A cross-sectional study","volume":"18","author":"Nowak","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0035-1547319","article-title":"Clinical updates in cystic fibrosis-related diabetes","volume":"36","author":"Brennan","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MCP.0b013e3283659e9f","article-title":"Pulmonary hypertension survival effects and treatment options in cystic fibrosis","volume":"19","author":"Tonelli","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1183\/09031936.00128706","article-title":"The effects of hypoxia on the cells of the pulmonary vasculature","volume":"30","author":"Pak","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1164\/rccm.201407-1382OC","article-title":"Pulmonary hypertension in cystic fibrosis with advanced lung disease","volume":"190","author":"Hayes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archpediatrics.2012.1177","article-title":"Early occurrence of obstructive sleep apnea in infants and children with cystic fibrosis","volume":"166","author":"Spicuzza","year":"2012","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1183\/09031936.02.00088702","article-title":"Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease","volume":"19","author":"Dancey","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Toledano, M.B., Mukherjee, S.K., Howell, J., Westaby, D., Khan, S.A., Bilton, D., and Simmonds, N.J. (2019). The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212779"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcf.2021.07.014","article-title":"The impact of liver disease on mortality in cystic fibrosis\u2014A systematic review","volume":"21","author":"Sasame","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101977","DOI":"10.1016\/j.clinre.2022.101977","article-title":"Prevalence and Characteristics of Cystic Fibrosis Liver Disease: A Study highlighting the lack of historical diagnosis","volume":"46","author":"Issa","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: Analysis of United Network for Organ Sharing data","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transpl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","article-title":"PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy","volume":"20","author":"Nichols","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: Sequela of living to adulthood with cystic fibrosis","volume":"128","author":"Aris","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-015-3343-3","article-title":"Bone Disease in cystic fibrosis: New pathogenic insights opening novel therapies","volume":"27","author":"Jacquot","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcf.2015.01.011","article-title":"Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period","volume":"14","author":"Putman","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_36","first-page":"2","article-title":"Bone health and disease in cystic fibrosis","volume":"20","author":"Marquette","year":"2016","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/rccm.200512-1943OC","article-title":"Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis","volume":"174","author":"Shead","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_38","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"1","author":"Jeffery","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jnci\/87.19.1486-a","article-title":"Childhood cancer and cystic fibrosis","volume":"87","author":"Robertson","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Scott, P., Anderson, K., Singhania, M., and Cormier, R. (2020). Cystic Fibrosis, CFTR, and Colorectal Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082891"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2147\/CMAR.S248539","article-title":"CFTR Functions as a Tumor Suppressor and Is Regulated by DNA Methylation in Colorectal Cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ijc.33431","article-title":"Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank","volume":"148","author":"Shi","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13256-021-03234-1","article-title":"Malignancies in patients with cystic fibrosis: A case series","volume":"16","author":"Appelt","year":"2022","journal-title":"J. Med. Case Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2016.01.002","article-title":"Colonoscopic screening shows increased early incidence and progression of adenomas in cystic fibrosis","volume":"15","author":"Niccum","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2016.07.011","article-title":"Cancer risk among lung transplant recipients with cystic fibrosis","volume":"16","author":"Fink","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jcf.2017.03.013","article-title":"Increased risk of PTLD in lung transplant recipients with cystic fibrosis","volume":"16","author":"Lowery","year":"2017","journal-title":"J. Cyst. Fibros."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:46:40Z","timestamp":1760125600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/6\/1305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["life13061305"],"URL":"https:\/\/doi.org\/10.3390\/life13061305","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}